Society for Clinical Research Sites
FOR IMMEDIATE RELEASE
SCRS Welcomes Endo International plc to the Global Impact Partner Program
Hanover, MD, June 17, 2020 – The Society for Clinical Research Sites (SCRS) announced today that Endo International plc has joined the organization as a Global Impact Partner (GIP). SCRS’ GIP Program provides a unique opportunity for sponsors, CROs and solution providers to engage with SCRS and its members in an impactful manner. Becoming a GIP demonstrates Endo’s commitment to clinical research sites, their desire to develop a deeper understanding of the needs of sites and contribute to the development and implementation of solutions in the marketplace.
“Endo is excited to become a partner of the SCRS organization,” said Rosie Filling, Vice President of R&D Operations at Endo. “Clinical research sites play a key role in the successful execution of any clinical trial. We look forward to listening to and learning from the voices of the clinical sites through SCRS, as well as being a valuable contributor to assess any potential changes or enhancements to make the clinical research experience the best it can be.”
“It’s clear that Endo prioritizes relationships with patients, investigators and sites to enhance the development of new medications and treatments while placing significant emphasis on patient safety. We are excited to partner with a team dedicated to successful clinical outcomes and the long-term sustainability of research sites,” said SCRS Vice President Sean Soth. “We are thrilled to welcome Endo to the Global Impact Partner (GIP) program and look forward to collaborating for a stronger site community.”
About Endo International plc
Endo International plc (NASDAQ: ENDP) is a highly focused specialty branded and generics pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland. Learn more at www.endo.com.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.